Sach & Associates successful in revoking EpiPen patent in Europe

Sach & Associates has been successful in revoking another EpiPen patent in European Patent Office (EPO) opposition proceedings. The opposition was filed against Pfizer's European EpiPen patent. The hearing took place in April 2018 and the written decision to revoke the patent issued in May 2018. This is the second successful opposition by ALK-Abello (represented by Sach & Associates) to Meridian Medical Technologies' EpiPen patents in Europe. The European patent revocation leaves Meridian Medical Technologies without patent protection for EpiPen in Europe.

The European Patent Office file for the oppositions can be found here:

https://register.epo.org/application?number=EP05783727

and here:

https://register.epo.org/application?number=EP10194414

A press report on the opposition can be found here:

https://www.lifesciencesipreview.com/news/epipen-patent-revoked-in-europe-2829

#EPIPEN #EuropeanPatentOfficeopposition

Featured Posts
Recent Posts
Archive
Search By Tags
No tags yet.
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • LinkedIn Social Icon

© 2018 Sach & Associates